Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Spotlight Pathology has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Spotlight Pathology's investors include Deepbridge Capital, UK Innovation & Science Seed Fund, River Capital, AXM Venture Capital, EHE Ventures.
Spotlight Pathology is headquartered in Manchester, United Kingdom.
Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Spotlight Pathology is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spotlight Pathology — Funding & Investors." VCBacked, March 11, 2026, https://www.vcbacked.co/company/spotlight-pathology. Accessed October 7, 2026.
VCBacked. (2026). Spotlight Pathology — Funding & Investors. Retrieved October 7, 2026, from https://www.vcbacked.co/company/spotlight-pathology
{{cite web |title=Spotlight Pathology — Funding & Investors |url=https://www.vcbacked.co/company/spotlight-pathology |website=VCBacked |access-date=October 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated